|
⚲
|
| Keyboard |
| Dennis Berman | |
|---|---|
| Firm | |
| Address | c/o Inhibikase Therapeutics, Inc 3350 Riverwood Parkway Se, Suite 1900 Atlanta, GA 30339 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | 021-515107 | Director | of 8.0 M |
||
| Inhibikase Therapeutics Inc | 021-472876 | Director | 4.2 M of 4.2 M |
||
| Tocagen Inc | 021-275725 | Executive Officer | 10.9 M of 13.0 M |
||
| Tocagen Inc | 021-197726 | Executive Officer | 46.2 M of 50.4 M |
||
| Tocagen Inc | 021-174443 | Executive Officer | 9.1 M of 15.0 M |
||
| Tocagen Inc | 021-152964 | Executive Officer | 15.3 M of 28.2 M |
||
| Tocagen Inc | 021-145396 | Executive Officer | 5.3 M of 12.0 M |
||
| Tocagen Inc | 021-111231 | Executive Officer | 7.8 M of 8.0 M |
||